Document is current
Any future updates will be listed below
-
Authors
Javor, Josh https://orcid.org/0000-0002-9556-0021
Ewoldt, Jourdan K.
Cloonan, Paige E.
Chopra, Anant
Luu, Rebeccah J.
Freychet, Guillaume https://orcid.org/0000-0001-8406-798X
Zhernenkov, Mikhail https://orcid.org/0000-0003-3604-0672
Ludwig, Karl
Seidman, Jonathan G.
Seidman, Christine E.
Chen, Christopher S.
Bishop, David J.
-
Funding
Funding for this research was provided by:
National Science Foundation (1647837, 1647837, 1647837, 1647837, 1647837, 1647837, 1647837, 1647837)
U.S. Department of Energy (DESC0012704, DESC0012704)
- License Information
-
More Information
Article History
Received: 28 August 2020
Revised: 13 November 2020
Accepted: 3 December 2020
First Online: 27 January 2021
Conflict of interest
: Drs. C.E. Seidman and J.G. Seidman are founders and own shares in MyoKardia Inc, a startup company that is developing therapeutics that target the sarcomere. MyoKardia had no role in performing or approving these studies. The other authors report no conflicts.
